Biopharma Shakti programme key enabler for India's journey towards value leadership: Dr Reddy''s Lab

"The Rs 10,000-crore Alongside the expansion of the national clinical trials network and strengthening of the CDSCO (Central Drugs Standard Control Organisation) with specialised scientific review and globally aligned timelines, these initiatives will enhance India's capacity to develop complex, high-value therapies, he further said.The addition of new NIPERs (National Institute of Pharmaceutical Education & Research) and the upgrading of existing ones will expand opportunities for advanced scientific educa ...